Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Augmedix, Inc.

Market Cap 116M 101M 93.88M 87.63M 165M 10.98B 166M 1.12B 434M 5.4B 436M 427M 18.75B P/E 2022
-2.39x
P/E 2023 -13.4x
Enterprise Value 95.78M 83.7M 77.42M 72.26M 136M 9.05B 137M 920M 358M 4.45B 360M 352M 15.46B EV / Sales 2022
1.75x
EV / Sales 2023 5.88x
Free-Float
99.74%
Yield 2022 *
-
Yield 2023 -
3 years 0.73
Extreme 0.73
6.25
5 years 0.73
Extreme 0.73
6.25
10 years 0.73
Extreme 0.73
10
Manager TitleAgeSince
Chief Executive Officer - 2024-10-01
Director of Finance/CFO - 2024-10-01
Chief Operating Officer - 2024-10-01
Director TitleAgeSince
Director/Board Member 63 2023-04-09
Director/Board Member - 2024-10-01
Date Insider Type Main position Quantity % Market Cap.
24-10-01Issuer sale

Founder

889,639 1.7999%
24-10-01Issuer sale

Director

212,583 0.4301%
24-10-01Issuer sale

Director

41,461 0.0839%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-.--%-48.12% 116M
-0.82%-3.03%-22.50%+39.10% 68.35B
-1.75%-1.61%+3.63%+91.18% 20.6B
-1.88%-4.71%-6.78%+1.99% 14.28B
-1.81%-2.22%-10.39%+4.37% 13.25B
-0.09%+2.47%+24.84%+34.45% 11.79B
-0.52%-2.98%+34.67%+103.57% 8.04B
+0.84%+0.38%+53.53%+93.78% 6.33B
-0.74%+15.89%+32.24%+131.36% 5.65B
-0.96%-2.53%+1.48%-6.74% 5.01B
Average -0.76%+1.02%+11.07%+44.50% 15.34B
Weighted average by Cap. -0.98%-1.75%-3.89%+46.75%

Financials

2022 2023
Net sales 30.93M 27.03M 25M 23.34M 43.81M 2.92B 44.13M 297M 116M 1.44B 116M 114M 4.99B 44.86M 39.19M 36.25M 33.84M 63.52M 4.24B 63.99M 431M 168M 2.08B 168M 165M 7.24B
Net income -24.45M -21.36M -19.76M -18.44M -34.63M -2.31B -34.88M -235M -91.37M -1.14B -91.79M -89.8M -3.95B -19.17M -16.75M -15.5M -14.46M -27.15M -1.81B -27.35M -184M -71.64M -891M -71.98M -70.42M -3.09B
Net Debt -4.28M -3.74M -3.46M -3.23M -6.06M -404M -6.1M -41.08M -15.98M -199M -16.06M -15.71M -690M -20.37M -17.8M -16.47M -15.37M -28.85M -1.93B -29.06M -196M -76.13M -946M -76.48M -74.82M -3.29B
Logo Augmedix, Inc.
Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
Employees
1,430
  1. Stock Market
  2. Stocks
  3. AUGX Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!